PRIMA1 and breast cancer: PRIMA-1, the precursor compound of PRIMA-1MET has been shown to induce nucleolar redistribution of mutp53 associated with p53 degradation via ubiquitination as a mechanism that removes the pro-survival function of mutp53 in a breast cancer model [73].